Assessment of Captopril and Nicardipine Effects on Chronic Occlusive Arterial Disease of the Lower Extremity Using Doppler Ultrasound

Abstract

The effects of two potent vasodilating drugs, captopril (C) (25 mg tid), nicar dipine (N) (20 mg tid), and placebo (P) were evaluated and compared, in 10 men (mean age of sixty-five years) with intermittent claudication from moderate to severe multilevel chronic occlusive arterial disease (COAD) of the lower extrem ity, by use of the Doppler ultrasonic method, at rest and after Carter's exercise test. All the examined subjects were normotensive, without diabetes or cardio pathy; all have been smokers.

The eight-week total protocol consisted of an initial two-week placebo run-in period followed by two active drug phases and a two-week placebo phase, ac cording to a double-blind, randomized, crossover design. At the end of each two-week period, ankle-arm index (AAI) and, following exercise, onset of lower extremity discomfort time (ODT), duration of exercise (ET), decrease of ankle systolic pressure after test (APD), and recovery time (RT) were determined. Moreover, at rest, just after exercise, and after recovery, simultaneous common femoral artery velocity waves were recorded and analyzed by a quantitative approach to detect the peripheral vasomotor adjustments.

None of the patients required the withdrawal of the active treatments. Com pared with P, C significantly reduced APD and RT, and N reduced RT and AAI; furthermore N caused a significant decrease in ODT, whereas C showed a trend, although not statistically significant, to increase ODT. Neither active therapy modified ET.

These results suggest that C and N have different short-term effects on pe ripheral circulation in COAD. During exercise, C induces hemodynamic im provement in the ischemic lower extremity probably by inhibition of the sympathetic system and consequent reduction in collateral vessel vasoconstric tion.

Get full access to this article

View all access options for this article.

References

Juergens JL , Bernatz PE : Arteriosclerosis obliterans. In: Peripheral Vascular Diseases , ed. by Fairbairn JF , Juergens JL , Spittal JA Jr. Philadelphia, WB Saunders, 1979, pp 179-216.

Young JR : Diseases of the peripheral arteries. In: The Heart , ed. by Hurst JW. New York, McGraw-Hill, 1986, pp 1339-1346.

Dahn I. , Ekman C. , Lassen N. , et al: On the conservative treatment of severe ischemia of the leg . Scand J Clin Lab Invest 19 (suppl 99):160-165, 1967.

Hertzer NR , Beven EG , Young JR : Coronary artery disease in peripheral vascular patients: A classification of 1000 coronary angiograms and results of surgical management. Ann Surg 199:223-233, 1984.

Vidt DG , Bravo EL , Fouad F. : Captopril. N Engl J Med 306:214-219, 1982.

Abrams WB , Davies RO , Ferguson RK : Overview: The role of angiotensin converting enzyme inhibitors in cardiovascular therapy. Fed Proc 43:1314-1321, 1984 .

Millard RW , Lathrop DA , Grupp G. , et al: Differential cardiovascular effects of calcium channel blocking agents: Potential mechanisms. Am J Cardiol 49:499-506, 1982.

Campbell BC , Kelman AW , Hillis W. : Noninvasive assessment of the haemodynamic effects of nicardipine in normotensive subjects. Br J Clin Pharmacol 20:55S-61S, 1985.

Longhini C. , Musacci GF , Ansani L. , et al: Peripheral hemodynamic response to angiotensin converting enzyme inhibitor single administration in hypertensive patients. Curr Ther Res 35:707-713, 1984.

10.

Simon A. , Levenson J. , Merli I. : Arteres et maladie hypertensive: intérêt de la inhibition calcique et expérience de la nicardipine. In: Nicardipine in Hypertension , ed. by Muiesan G , Rhodes, May 1-2, 1987, pp 32-39.

11.

Clarke B. , Grant D. , Patmore L. , et al: Comparative calcium entry blocking properties of nicardipine, nifedipine and PY 108068 on cardiac and vascular smooth muscle. Br J Pharmacol 79:333P, 1983.

12.

Kempczinski RF , Rutherford RB : Current status of the vascular diagnostic laboratory. Adv Surg 12:1-6, 1978.

13.

Carter SA : Response of ankle systolic pressure to leg exercise in mild or questionable arterial disease. N Engl J Med 287:578-582, 1972.

14.

Fronek A. , Coel M. , Bernstein EF : Quantitative ultrasonographic studies of lower extremity flow velocities in health and disease. Circulation 53:957-960, 1976.

15.

ColtonT. : Statistics in Medicine. Boston, Little, Brown and Company, 1974, pp 131-136.

16.

Criqui M. , Fronek A. , Barrett-Connor E. , et al: The prevalence of peripheral arterial disease in a defined population . Circulation 71:510-515, 1985.

17.

Skinner JS , Strandness DE Jr : Exercise and intermittent claudication. Circulation 36:23-29, 1967.

18.

Fronek A. , Coel M. , Bernstein DF : The importance of combined multisegmental pressure and Doppler flow velocity studies in the diagnosis of peripheral arterial occlusive disease . Surgery 84:840-847, 1978.

19.

Strandness DE Jr: Doppler methods for analysis of arterial and venous disorders. In: The Heart, ed. by Hurst JW. New York, McGraw-Hill, 1986, pp 1974-1977.

20.

Dilley RB , Fronek A. : Quantitative velocity measurement in arterial disease of the lower extremity . In: Noninvasive Diagnostic Techniques in Vascular Disease , ed. by Bernstein EF. St. Louis, The CV Mosby Co, 1982 , pp 350-359.

21.

Strandness DE Jr : Exercise ankle pressure measurements in arterial disease. In: Noninvasive Diagnostic Techniques in Vascular Disease, ed. by Bernstein EF. St. Louis , The CV Mosby Co, 1982, pp 370-376.

22.

Sharpe DN , Douglas JE , Coxon RJ , et al: Low-dose captopril in chronic heart failure: Acute haemodynamic effects and long-term treatment. Lancet ii:1154-1157, 1980.

23.

Forette F. , Bellet M. , Henry JF , et al: Effect of nicardipine in elderly hypertensive patients. Br J Clin Pharmacol 20:125S-129S, 1985.

24.

Shepherd J. : Circulation to skeletal muscle. In: Handbook of Physiology , ed. by Shepherd J , Abbound F , Geiger S. Bethesda, Md, American Physiological Society , 1983, pp 319-329.

25.

MacGregor GA , Markandu ND , Roulson JE , et al: Maintenance of blood pressure by the renin-angiotensin system in normal man. Nature 291:329-331, 1981.

26.

Hatton R. , Clough D. , Faulkner K. , et al: Angiotensin converting enzyme inhibitor resets baroceptor reflexes in conscious dogs. Hypertension 3:676-681, 1981.

27.

Laragh HJ : Conceptual diagnostic and therapeutic dimensions of renin-system profiling of hypertensive disorders and of congestive heart failure: Four new research frontiers. In: Hypertension and the Angiotensin System, ed. by Doyle AE , Beam AG. New York, Raven Press , 1983, pp 47-69.

28.

Erne P. , Bolli P. , Bertel O. , et al: Factors influencing the hypotensive effects of calcium antagonists . Hypertension 5 (suppl II):97-102, 1983.

29.

Antignani PL , Amato B. , De Fabritiis A. , et al: Il Doppler ad Onda Continua. Torino, Centro Scientifico Torinese, 1985, pp 95-124.

30.

Thulesius O. : Haemodynamic studies on experimental obstruction of the femoral artery in the cat. Acta Physiol Scand 67 (suppl 199):5-95, 1962.

31.

Matsubara J. : Sympathetic innervation of the human leg arteries . Virchows Arch (Pathol Anat) 376:343-351, 1977.

32.

Agerskov K. , Henriksen O. , Tonnesen K. , et al: Constriction of collateral arteries induced by 'head-up tilt' in patients with occlusive arterial disease of the legs. Cardiovasc Res 15:675-679, 1981.

33.

Kotchen TA , Hartley LH , Rice TW , et al: Renin, nor-epinephrine, and epinephrine responses to graded exercise. J Appl Physiol 31:178-184, 1971.

34.

Fagard R. , Amery A. , Reybrouck T. : Effectsof angiotensin antagonism on hemodynamics, renin, and catecholamines during exercise. J Appl Physiol 43:440-444, 1977.

35.

Fagard R. , Lijnen P. , Amery A. : Hemodynamic response to captopril at rest and during exercise in hypertensive patients. Am J Cardiol 49:1569-1571, 1982 .

36.

Fagard R. , Amery A. , Reybrouck T. : Effects of antagonism at rest and during exercise in sodium depleted man. J Appl Physiol 44:403-407, 1978.

37.

Bellocci F. , Ansalone G. , Scabbia E. , et al: Sustained beneficial effects of nifedipine in chronic refractory heart failure (Abstract). Am J Cardiol 47:407, 1981.

38.

Reit E. : Interaction of angiotensin with the autonomic nervous system. Fed Proc 31:1331-1364, 1972 .

39.

McAubbin JW Peripheral effects of angiotensin on the autonomic nervous system . In: Angiotensin Handbook of Experimental Pharmacology, Vol. 37, ed. by Page IH , Bumpus FM. New York, Springer-Verlag, 1979, pp 417-423.

40.

Antoniaccio MJ , Kerwin L. : Pre- and postjunctional inhibition of vascular sympathetic function by captopril in SHR. Implication of vascular angiotensin II in hypertension and antihypertensive action of captopril. Hypertension 31:54-62, 1981.